{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T09:47:48Z","timestamp":1778320068260,"version":"3.51.4"},"reference-count":31,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2024,1,31]],"date-time":"2024-01-31T00:00:00Z","timestamp":1706659200000},"content-version":"vor","delay-in-days":230,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2023,6,15]],"date-time":"2023-06-15T00:00:00Z","timestamp":1686787200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000038","name":"U.S. Food and Drug Administration","doi-asserted-by":"publisher","award":["#75F40120C00195"],"award-info":[{"award-number":["#75F40120C00195"]}],"id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000038","name":"U.S. Food and Drug Administration","doi-asserted-by":"publisher","award":["#75F40120C00195"],"award-info":[{"award-number":["#75F40120C00195"]}],"id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>In Duchenne muscular dystrophy (DMD) and other rare diseases, recruiting patients into clinical trials is challenging. Additionally, assigning patients to long-term, multi-year placebo arms raises ethical and trial retention concerns. This poses a significant challenge to the traditional sequential drug development paradigm. In this paper, we propose a small-sample, sequential, multiple assignment, randomized trial (snSMART) design that combines dose selection and confirmatory assessment into a single trial. This multi-stage design evaluates the effects of multiple doses of a promising drug and re-randomizes patients to appropriate dose levels based on their Stage 1 dose and response. Our proposed approach increases the efficiency of treatment effect estimates by (i) enriching the placebo arm with external control data, and (ii) using data from all stages. Data from external control and different stages are combined using a robust meta-analytic combined (MAC) approach to consider the various sources of heterogeneity and potential selection bias. We reanalyze data from a DMD trial using the proposed method and external control data from the Duchenne Natural History Study (DNHS). Our method's estimators show improved efficiency compared to the original trial. Also, the robust MAC-snSMART method most often provides more accurate estimators than the traditional analytic method. Overall, the proposed methodology provides a promising candidate for efficient drug development in DMD and other rare diseases.<\/jats:p>","DOI":"10.1111\/biom.13887","type":"journal-article","created":{"date-parts":[[2023,6,16]],"date-time":"2023-06-16T06:31:22Z","timestamp":1686897082000},"page":"3612-3623","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Dynamic Enrichment of Bayesian Small-Sample, Sequential, Multiple Assignment Randomized Trial Design Using Natural History Data: A Case Study from Duchenne Muscular Dystrophy"],"prefix":"10.1093","volume":"79","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4838-0842","authenticated-orcid":false,"given":"Sidi","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Biostatistics, University of Michigan , Ann Arbor, Michigan , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelley M.","family":"Kidwell","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, University of Michigan , Ann Arbor, Michigan , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4001-3036","authenticated-orcid":false,"given":"Satrajit","family":"Roychoudhury","sequence":"additional","affiliation":[{"name":"Pfizer Inc. , New York, New York , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2023,6,15]]},"reference":[{"issue":"3","key":"2024020107184186300_biom13887-bib-0001","first-page":"663","article-title":"A Bayesian group sequential small n sequential multiple-assignment randomized trial","volume":"69","author":"Chao","year":"2020","journal-title":"Journal of the Royal Statistical Society: Series C (Applied Statistics)"},{"issue":"1","key":"2024020107184186300_biom13887-bib-0002","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13023-020-01430-8","article-title":"Global epidemiology of Duchenne muscular dystrophy: an updated systematic review and meta-analysis","volume":"15","author":"Crisafulli","year":"2020","journal-title":"Orphanet Journal of Rare Diseases"},{"key":"2024020107184186300_biom13887-bib-0003","volume-title":"A modified Bayesian power prior approach with applications in water quality evaluation","author":"Duan","year":"2005"},{"issue":"4","key":"2024020107184186300_biom13887-bib-0004","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1002\/sim.8813","article-title":"Bayesian methods to compare dose levels with placebo in a small n, sequential, multiple assignment, randomized trial","volume":"40","author":"Fang","year":"2021","journal-title":"Statistics in Medicine"},{"key":"2024020107184186300_biom13887-bib-0005","first-page":"1","article-title":"Comparing dose levels to placebo using a continuous outcome in a small n, sequential, multiple assignment, randomized trial (snSMART)","volume":"00","author":"Fang","year":"2022","journal-title":"Statistics in Biopharmaceutical Research"},{"issue":"2","key":"2024020107184186300_biom13887-bib-0006","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1002\/sim.8776","article-title":"Design and analysis considerations for utilizing a mapping function in a small sample, sequential, multiple assignment, randomized trials with continuous outcomes","volume":"40","author":"Hartman","year":"2021","journal-title":"Statistics in Medicine"},{"issue":"3","key":"2024020107184186300_biom13887-bib-0007","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1111\/j.1541-0420.2011.01564.x","article-title":"Hierarchical commensurate and power prior models for adaptive incorporation of historical information in clinical trials","volume":"67","author":"Hobbs","year":"2011","journal-title":"Biometrics"},{"issue":"1","key":"2024020107184186300_biom13887-bib-0008","first-page":"46","article-title":"Power prior distributions for regression models","volume":"15","author":"Ibrahim","year":"2000","journal-title":"Statistical Science"},{"issue":"431","key":"2024020107184186300_biom13887-bib-0009","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1080\/01621459.1995.10476592","article-title":"A reference Bayesian test for nested hypotheses and its relationship to the Schwarz criterion","volume":"90","author":"Kass","year":"1995","journal-title":"Journal of the American Statistical Association"},{"issue":"4","key":"2024020107184186300_biom13887-bib-0010","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1093\/biostatistics\/kxz066","article-title":"Dynamic borrowing in the presence of treatment effect heterogeneity","volume":"22","author":"Kotalik","year":"2021","journal-title":"Biostatistics"},{"key":"2024020107184186300_biom13887-bib-0011","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1177\/2168479018778282","article-title":"Minimizing patient burden through the use of historical subject-level data in innovative confirmatory clinical trials: review of methods and opportunities","volume":"52","author":"Lim","year":"2018","journal-title":"Therapeutic Innovation & Regulatory Science"},{"issue":"5","key":"2024020107184186300_biom13887-bib-0012","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/pst.1879","article-title":"Propensity score matched augmented controls in randomized clinical trials: a case study","volume":"17","author":"Lin","year":"2018","journal-title":"Pharmaceutical Statistics"},{"key":"2024020107184186300_biom13887-bib-0013","doi-asserted-by":"crossref","first-page":"S121","DOI":"10.1016\/j.nmd.2018.06.347","article-title":"Minimal detectable change in the North Star Ambulatory Assessment (NSAA) in Duchenne muscular dystrophy (DMD)","volume":"28","author":"Muntoni","year":"2018","journal-title":"Neuromuscular Disorders"},{"issue":"4","key":"2024020107184186300_biom13887-bib-0014","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.nmd.2022.02.009","article-title":"Real-world and natural history data for drug evaluation in Duchenne muscular dystrophy: suitability of the North Star Ambulatory Assessment for comparisons with external controls","volume":"32","author":"Muntoni","year":"2022","journal-title":"Neuromuscular Disorders"},{"issue":"28","key":"2024020107184186300_biom13887-bib-0015","doi-asserted-by":"crossref","first-page":"3562","DOI":"10.1002\/sim.3722","article-title":"A note on the power prior","volume":"28","author":"Neuenschwander","year":"2009","journal-title":"Statistics in Medicine"},{"issue":"1","key":"2024020107184186300_biom13887-bib-0016","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1177\/1740774509356002","article-title":"Summarizing historical information on controls in clinical trials","volume":"7","author":"Neuenschwander","year":"2010","journal-title":"Clinical Trials"},{"issue":"3","key":"2024020107184186300_biom13887-bib-0017","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1080\/19466315.2016.1174149","article-title":"On the use of co-data in clinical trials","volume":"8","author":"Neuenschwander","year":"2016","journal-title":"Statistics in Biopharmaceutical Research"},{"issue":"2","key":"2024020107184186300_biom13887-bib-0018","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1111\/biom.13252","article-title":"Predictively consistent prior effective sample sizes","volume":"76","author":"Neuenschwander","year":"2020","journal-title":"Biometrics"},{"issue":"5","key":"2024020107184186300_biom13887-bib-0019","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1111\/rssc.12602","article-title":"Bayesian modelling strategies for borrowing of information in randomised basket trials","volume":"71","author":"Ouma","year":"2022","journal-title":"Journal of the Royal Statistical Society. Series C: Applied Statistics"},{"key":"2024020107184186300_biom13887-bib-0020","volume-title":"rjags: Bayesian graphical models using MCMC. R package version 4-13","author":"Plummer","year":"2022"},{"issue":"3","key":"2024020107184186300_biom13887-bib-0021","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0021-9681(76)90044-8","article-title":"The combination of randomized and historical controls in clinical trials","volume":"29","author":"Pocock","year":"1976","journal-title":"Journal of Chronic Diseases"},{"issue":"1","key":"2024020107184186300_biom13887-bib-0022","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/biomet\/70.1.41","article-title":"The central role of the propensity score in observational studies for causal effects","volume":"70","author":"Rosenbaum","year":"1983","journal-title":"Biometrika"},{"issue":"4","key":"2024020107184186300_biom13887-bib-0023","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1111\/biom.12242","article-title":"Robust meta-analytic-predictive priors in clinical trials with historical control information","volume":"70","author":"Schmidli","year":"2014","journal-title":"Biometrics"},{"key":"2024020107184186300_biom13887-bib-0024","volume-title":"Bayesian approaches to clinical trials and health-care evaluation, vol. 13","author":"Spiegelhalter","year":"2004"},{"key":"2024020107184186300_biom13887-bib-0025","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.cct.2015.11.010","article-title":"A small n sequential multiple assignment randomized trial design for use in rare disease research","volume":"46","author":"Tamura","year":"2016","journal-title":"Contemporary Clinical Trials"},{"key":"2024020107184186300_biom13887-bib-0026","volume-title":"Interacting with the FDA on complex innovative trial designs for drugs and biological products","author":"U.S. Food and Drug Administration","year":"2020"},{"issue":"2","key":"2024020107184186300_biom13887-bib-0027","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1002\/bimj.201900376","article-title":"A bias-corrected meta-analysis model for combining, studies of different types and quality","volume":"63","author":"Verde","year":"2021","journal-title":"Biometrical Journal"},{"issue":"2","key":"2024020107184186300_biom13887-bib-0028","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1177\/0962280216631359","article-title":"Extrapolation of efficacy and other data to support the development of new medicines for children: a systematic review of methods","volume":"27","author":"Wadsworth","year":"2018","journal-title":"Statistical Methods in Medical Research"},{"key":"2024020107184186300_biom13887-bib-0029","volume-title":"snSMART: small n sequential multiple assignment randomized trial methods. R package version 0.2.2","author":"Wang","year":"2022"},{"issue":"6","key":"2024020107184186300_biom13887-bib-0030","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1080\/10543406.2020.1815032","article-title":"Sample size determination for Bayesian analysis of small n sequential, multiple assignment, randomized trials (snSMARTs) with three agents","volume":"30","author":"Wei","year":"2020","journal-title":"Journal of Biopharmaceutical Statistics"},{"issue":"26","key":"2024020107184186300_biom13887-bib-0031","doi-asserted-by":"crossref","first-page":"3723","DOI":"10.1002\/sim.7900","article-title":"A Bayesian analysis of small n sequential multiple assignment randomized trials (snSMARTs)","volume":"37","author":"Wei","year":"2018","journal-title":"Statistics in Medicine"}],"container-title":["Biometrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/biometrics\/article-pdf\/79\/4\/3612\/56393419\/biometrics_79_4_3612.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/biometrics\/article-pdf\/79\/4\/3612\/56393419\/biometrics_79_4_3612.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T07:20:58Z","timestamp":1706772058000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/biometrics\/article\/79\/4\/3612\/7587547"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,15]]},"references-count":31,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,6,15]]},"published-print":{"date-parts":[[2023,12,1]]}},"URL":"https:\/\/doi.org\/10.1111\/biom.13887","relation":{},"ISSN":["0006-341X","1541-0420"],"issn-type":[{"value":"0006-341X","type":"print"},{"value":"1541-0420","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,12]]},"published":{"date-parts":[[2023,6,15]]},"assertion":[{"value":"2022-11-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-05-26","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-06-15","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}